Haemonetics (HAE) Net Cash Flow Growth (3y) (2012 - 2026)
Haemonetics (HAE) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 129.29% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -48.90% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -65.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | -58.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -58.11% |
| Dec 27, 2025 | 71.43% |
| Sep 27, 2025 | -47.83% |
| Jun 28, 2025 | 23.06% |
| Mar 29, 2025 | -38.91% |
| Dec 28, 2024 | -14.82% |
| Sep 28, 2024 | -65.27% |
| Jun 29, 2024 | 120.48% |
| Mar 30, 2024 | -63.82% |
| Dec 30, 2023 | -19.74% |
| Sep 30, 2023 | 223.59% |
| Jul 1, 2023 | -71.33% |
| Apr 1, 2023 | 68.05% |
| Dec 31, 2022 | -53.84% |
| Oct 1, 2022 | 33.80% |
| Jul 2, 2022 | -57.74% |
| Apr 2, 2022 | 19.78% |
| Jan 1, 2022 | 43.98% |
| Oct 2, 2021 | 28.75% |
| Jul 3, 2021 | -49.18% |